4//SEC Filing
Hislop Colin 4
Accession 0001214659-13-002945
CIK 0001316175other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 1:07 PM ET
Size
6.8 KB
Accession
0001214659-13-002945
Insider Transaction Report
Form 4
Hislop Colin
Sr. VP, Cardiovasc. Prod.
Transactions
- Award
Stock option (right to buy)
2013-05-17+1,300,000→ 1,300,000 totalExercise: $0.61Exp: 2023-05-17→ Common Stock (1,300,000 underlying)
Holdings
- 144,091
Common Stock
- 15,183(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This stock option granted under our 2013 Stock Option and Incentive plan, which was adopted by the Board of Directors on March 25, 2013 and approved by the shareholders on May 16, 2013, vests annually over four years beginning March 25, 2013 (?the Vesting Start Date?). The Stock Option is completely vested on the fourth anniversary of the vesting start date.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001314902
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 1:07 PM ET
- Size
- 6.8 KB